Effect of Pistacia lentiscus oil on experimental pulmonary fibrosis

##plugins.themes.academic_pro.article.sidebar##

Published Dec 7, 2016
Download
pdf
Vol. 94 No. 7 (2016): Issue Jul 2016

##plugins.themes.academic_pro.article.main##

Anouar Abidi
Raja Serairi Beji
Nadia Kourda
Samir Ennigrou
Riadh Ksouri
Saloua Jameleddine

Abstract

Abstract
Background: Idiopathic pulmonary fibrosis (IPF) is a chronic disease characterized by histopathological lesions in lung tissue. This is the most common and most severe idiopathic interstitial pneumonias. Current treatments are based on the combination of corticosteroids and immunosuppressants, but their effectiveness is still debated.
Purpose of work: Testing the preventive effect of Pistacia Lentiscus oil, known for its antioxidant, anti-mutagenic and anti-proliferative effects, on a model of experimental lung fibrosis.
Methods: Two groups of rats received an intratracheal injection of bleomycin (4.5 mg / kg). The first group, control (n = 20 rats), has received no treatment. The second group was treated with Pistacia Lentiscus oil (n = 20 rats) for 30 days before fibrosis induction, by daily gavage oil Pistacia Lentiscus oil (3,33ml / kg). This treatment was continued for 10 days. At the end of the experimental period, all rats were sacrificed and the lung tissue was examined histopathologically and immunostained for TGFβ.
Results: The chromatographic profile oil Pistacia Lentiscus oil shows the dominance of two fatty acids that are linoleic acid and palmitic acid representing respectively 70.57 and 24.67%. Our results also show a decrease in the distribution of TGFβ both at the level of the inflammatory infiltrate and at the level of the pulmonary parenchyma histiocytes of rats treated with Pistacia Lentiscus oil compared with control rats. However, these changes are not accompanied by statistically significant changes of fibrosis score and inflammatory index.
Conclusion: Our results are interesting to consider. Further studies using higher doses of Pistacia Lentiscus oil are important to conduct.

Keywords:

Pulmonary fibrosis, inflammation, TGFβ, Pistacia Lentiscus oil, rat, Bleomycin.

##plugins.themes.academic_pro.article.details##

References

  1. Tominaja J, Sakai F, Johkoh T, et al. Diagnostic certainty of idiopathic pulmonary fibrosis/usual interstitial pneumonia: the effect of the integrated clinico-radiological assessment. Eur J Radio 2015; 84: 2640-5.
  2. Boniface S, Gaubert JY, Chetaille B, et al. Classification 2002 des pneumopathies interstitielles idiopathiques. Rev Med Interne 2004 ; 25: 891-905.
  3. Cottin V, Cordier JF. Fibrose pulmonaire idiopathique. Presse Med 2008.
  4. Cottin V, Cordier JF. Fibrose pulmonaire idiopathique. Rev Prat 2006 ; 56 :1165-71.
  5. Selman M, King Jr T E, Pardo A. Idiopathic pulmonary fibrosis: prevailing and evolving hypotheses about its pathogenesis and implications for therapy. Ann Intern Med 2001; 134:136-51.
  6. Crestani B, Sylvain MA, Schneider S. Traitements médicamenteux de la fibrose pulmonaire idiopathique. Pneumol Clin 2005; 61: 221-31.
  7. Owen J D. Clinical review: idiopathic pulmonary Fibrosis - Past, present and future. Resp Med 2006; 100: 1871-85.
  8. Nikbakht J, Hemmati AA, Arzi A, Mansouri M T, Rezaie A, Ghafourain M. Protective effect of gallic acid against bleomycin-induced pulmonary fibrosis in rats. Pharmacol resp 2015; 67: 1061-7.
  9. Yu YF, Macaulay DS, Reichmann WM, Wu EQ, Nathan SD. Association of early suspected acute exacerbations of idiopathic pulmonary fibrosis with subsequent clinical outcomes and healthcare resource utilization. Resp Med 2015; 109 (12): 1582-8.
  10. Serairi Beji R, Msilini N, Abidi A, Saidi O, Jameleddine S, Ksouri R. Protective Effect of ATRA on Bleomycin Induced Lung Fibrosis in Rat. Med chem 2014; 4 (9): 611-6.
  11. Yacoubi L, Rabaoui L, Hamdaoui MH, et al. Anti-oxidative and anti-inflammatory effects of Trigonella foenum-graecum Linnaeus, 1753 (Fenugreek) seed extract in experimental pulmonary fibrosis. J Med Plants Res 2011; 5 (17): 4315-25.
  12. Klibert F, Boumendjel A, Khiari M, El Feki A, Abdennour C, Messarah M. Oxidative stress- related liver dysfunction by sodium arsenite: Alleviation by Pistacia lentiscus oil. Pharm Biol 2016; 54 (2):354-63
  13. Duru M E, Harmandar M, Cakir A, et al. Chemical composition and antifungal properties of essential oils of three Pistacia species. Fitoterapia 2003; 74:170-6.
  14. Ljubuncic P, Song H, Bomzon A, et al. The effects of aqueous extracts prepared from the leaves of Pistacia lentiscus in experimental liver disease. J Ethnopharmacol 2005; 100:198-204.
  15. Goto H, Senba T, Sato M, Minami T. Intratracheal administration of bleomycin via a catheter in unanesthezied rats. Exp Anim 2004; 53:113-9.
  16. AshcroftT, Simpson JM, Timbrell V. Simple method of estimating severity of pulmonary fibrosis on a numerical scale. J Clin Pathol 1988; 41: 467-70.
  17. Della Latta V, Ceccettini A, Del Ry S, Morales MA. Bleomycin in the setting of lung fibrosis induction: From biological mechanisms to counteractions. Pharmacol Res. 2015; 97:122-30.
  18. Chryssavgi G, Papageorgiou V, Athanasios M, Kibouris T, Komaitis M. Essential oil composition of Pistacia lentiscus L. and Myrtus communis L.: Evaluation of antioxidant capacity of methanolic extracts. Food Chem 2008; 107: 1120-30
  19. Balan KV, Prince J, Han Z, et al. Antiproliferative activity and induction of apoptosis in human colon cancer cells treated in vitro with constituents of a product derived from Pistacia lentiscus.L. var. chia. Phytomed 2007; 14:263-72.
  20. Murray M, Hraiki A, Bebaw YM, Pazderka C, Rawling T. Anti-tumor activities of lipids and lipid analogues and their development as potential anticancer drugs. Pharmacol Ther 2015;150: 109-28
  21. Choi JS, Park NH, Hwang SY, et al. The antibacterial activity of various saturated and unsaturated fatty acids against several oral pathogens. J Environ Biol 2013; 34:673-6.
  22. Cotogni P, Muzio G, Trombetta A, Ranieri VM, Canuto RA. Impact of the omega-3 to omega-6 polyunsaturated fatty acid ratio on cytokine release in human alveolar cells. J Parenter Enteral Nutr 2011; 35:114-21.
  23. Mezni F, Khouja ML, Gregoire S, Martine L, Khaldi A, Berdeaux O. Effect of growing area on tocopherols, carotenoids and fatty acid composition of Pistacia lentiscus edible oil. Nat Prod Res 2014; 28: 1225-30.
  24. Xiao Z, Zhang J, Peng X, et al. The Notch γ-secretase inhibitor ameliorates kidney fibrosis via inhibition of TGF-β/Smad2/3 signaling pathway activation. Int J Biochem Cell Biol 2014; 55: 65-71.
  25. Gail EMM, Kjetil A, Sarah E G, Martin K, Gauldie J. The transforming growth factor-beta (TGFβ) family and pulmonary fibrosis. Drug Discovery Today: Disease Mechanisms 2006; 3: 99-103.
  26. Chen T, Nie H, Gao X, et al. Epithelial-mesenchymal transition involved in pulmonary fibrosis induced by multi-walled carbon nanotubes via TGF-beta/Smad signaling pathway. Toxicol Lett 2014; 226: 150-62.
  27. Chung-Ming C, Hsiu-Chu C, Hsun-Hui H, Leng-Fang W. Transforming growth factor-β1 upregulation is independent of angiotensin in paraquat-induced lung fibrosis 2005; 216:181-7.
  28. Calabresi C, Arosio B, Galimberti L, et al. Natural aging, expression of fibrosis-related genes and collagen deposition in rat lung. Exp Gerontol 2007 ; 42: 1003-11.
  29. Peng L, Zhou Y, Dong L, et al. TGF-β1 Upregulates the Expression of Triggering Receptor Expressed on Myeloid Cells 1 in Murine Lungs. Sci Rep 2016; 6:18946-30.
  30. Epa AP, Thatcher TH, Pollock SJ. Normal Human Lung Epithelial Cells Inhibit Transforming Growth Factor-β Induced Myofibroblast Differentiation via Prostaglandin E2. PLoS One 2015; 10: e0135266.
  31. Mc Anulty RJ, Campa JS, Cambrey AD, Laurent GJ. The effect of transforming growth factor β on rates of procollagen synthesis and degradation in vitro. Biochim Biophys Acta 1991; 1091: 231-5.
  32. Zhao Y, Shah D U. Expression of transforming growth factor-β type I and type II receptors is altered in rat lungs undergoing bleomycin-induced pulmonary fibrosis. Exp Mol Pathol 2000; 69: 67-78.